journal article·2018-04

Improved hemodialysis with hemocompatible polyethersulfone hollow fiber membranes: In vitro performance

Surendra Kumar Verma, Akshay Modi, Atul Kumar Singh, Rohit Teotia, Jayesh Bellare

Publisher page

Abstract

Abstract We show that addition of nanozeolite (NZ) and vitamin E D‐α‐Tocopherol polyethylene glycol succinate (TPGS or T) considerably improves the performance of polyethersulfone (PES or P) hollow fiber membrane (HFM) for hemodialysis. Nanocomposite HFMs were manufactured using PES as a polymer, TPGS as an additive and NZ as a filler to give a composite membrane called PT‐NZ. HFMs were spun by dry‐wet spinning principle based on liquid‐liquid phase separation. TPGS and NZ were successfully incorporated in HFMs, as confirmed by EDX elemental mapping. The resultant PT‐NZ HFMs had improved hemocompatibility: lower percent hemolysis (0.28% in batch mode and 0.32% in continuous mode), lower platelet adhesion, higher coagulation time and lower protein adsorption (16.34 µg/cm2), compared with P, PT, and commercial (F60S) HFMs. The ultrafiltration coefficient of PT‐NZ HFM‐based module (274.59 mL/m2/h/mmHg) was ∼1.5‐times higher than that of F60S membranes (151.67 mL/m2/h/mmHg), and the solute rejection of both the membranes was comparable. The toxin clearance performance of lab‐scale PT‐NZ HFM‐based hemodialyzer with uremic toxin spiked goat blood was remarkably higher (five times) than that of F60S. Hence, the synthesized PT‐NZ HFMs are a potentially attractive membrane material for hemodialysis application, particularly due to decreased treatment time and minimal side reactions. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 1286–1298, 2018.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Membrane Separation Technologies · Dialysis and Renal Disease Management · Muscle and Compartmental Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering Indian Institute of Technology Bombay Mumbai 400076 India

Centre for Research in Nanotechnology and Science, Indian Institute of Technology Bombay Mumbai 400076 India

Department of Biosciences and Bioengineering Indian Institute of Technology Bombay Mumbai 400076 India

Wadhwani Research Center for Bioengineering Indian Institute of Technology Bombay Mumbai 400076 India

References (41)

Show source-provided references
1. 10.1016/S0140-6736(11)60178-510.1016/S0140-6736(11)60178-5 ↗
2. 10.1053/j.ackd.2011.09.00110.1053/j.ackd.2011.09.001 ↗
3. 10.1016/j.memsci.2007.05.01210.1016/j.memsci.2007.05.012 ↗
4. 10.1007/s10856-007-3006-910.1007/s10856-007-3006-9 ↗
5. High‐performance membrane dialyzers
6. 10.1007/978-3-319-12478-010.1007/978-3-319-12478-0 ↗
7. 10.1159/00032895410.1159/000328954 ↗
8. 10.1016/j.memsci.2006.03.01010.1016/j.memsci.2006.03.010 ↗
9. 10.1007/s10047-008-0417-410.1007/s10047-008-0417-4 ↗
10. Effect of monosodium glutamate additive on performance of dialysis membrane
11. Preparation and characteristics of polysulfone dialysis composite membranes modified with nanocrystalline cellulose10.15376/biores.6.2.1670-1680 ↗
12. Preparation of cellulose acetate dialysis membrane using D–glucose monohydrate as additive
13. 10.1016/j.biomaterials.2010.09.00510.1016/j.biomaterials.2010.09.005 ↗
14. 10.1016/j.cej.2012.05.03710.1016/j.cej.2012.05.037 ↗
15. 10.1002/app.3499810.1002/app.34998 ↗
16. 10.1039/C4RA13460E10.1039/C4RA13460E ↗
17. 10.1007/s00396-015-3801-710.1007/s00396-015-3801-7 ↗
18. 10.1046/j.1537-2995.2001.41121606.x10.1046/j.1537-2995.2001.41121606.x ↗
19. 10.1016/S0376-7388(00)00340-910.1016/S0376-7388(00)00340-9 ↗
20. Peinemann K.‐V · 2011
21. 10.3109/00365513.2011.55810610.3109/00365513.2011.558106 ↗
22. 10.1016/j.biomaterials.2003.08.02710.1016/j.biomaterials.2003.08.027 ↗
23. 10.1016/j.biomaterials.2004.04.03910.1016/j.biomaterials.2004.04.039 ↗
24. 10.1016/j.memsci.2012.03.01510.1016/j.memsci.2012.03.015 ↗
25. 10.1039/C5RA16515F10.1039/C5RA16515F ↗
26. 10.1039/C6RA13293F10.1039/C6RA13293F ↗
27. 10.1007/s12221-009-0001-410.1007/s12221-009-0001-4 ↗
28. GuytonAC.Human physiology and mechanisms of disease. WB Saunders Co 1992.
29. 10.1111/j.1749-6632.1987.tb33038.x10.1111/j.1749-6632.1987.tb33038.x ↗
30. 10.1146/annurev.ms.26.080196.00205310.1146/annurev.ms.26.080196.002053 ↗
31. 10.1097/00002480-199339040-0002710.1097/00002480-199339040-00027 ↗
32. 10.17795/nmsjournal2176410.17795/nmsjournal21764 ↗
33. Mandelbrot D. High‐flux dialysis. The kidney transplant/dialysis association patient handbook.1999.
34. 10.1002/app.1994.07054031310.1002/app.1994.070540313 ↗
35. 10.1021/ie901896310.1021/ie9018963 ↗
36. 10.3390/membranes501012010.3390/membranes5010120 ↗
37. 10.3390/membranes604004510.3390/membranes6040045 ↗
38. 10.1080/0091403090308152110.1080/00914030903081521 ↗
39. 10.1002/jbm.a.3598610.1002/jbm.a.35986 ↗
40. Short‐term hemodialysis treatment in dogs and cats with total uretic obstruction
41. Hemodialysis in a dog with acute renal failure from currant toxicity